The Endocannabinoid System as a Potential Therapeutic Target for HIV-1-Associated Neurocognitive Disorder.

Chu, Liuxi; Shu, Zheng; Gu, Xinpei; Wu, Yan; Yang, Jin; Deng, Huihua

Chu, Liuxi; Shu, Zheng; Gu, Xinpei; Wu, Yan; Yang, Jin; Deng, Huihua.

Afiliação

Chu L; Department of Brain and Learning Science, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
Shu Z; Key Laboratory of Child Development and Learning Science (Southeast University), Ministry of Education, Nanjing, China.
Gu X; Department of Child Development and Education, Research Center for Learning Science, Southeast University, Nanjing, China.
Wu Y; Clinical Nutrition Department, The Third Affiliated Hospital of Shandong First Medical University, Jinan, China.
Yang J; Department of Human Anatomy, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Deng H; Department of Brain and Learning Science, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.

Cannabis Cannabinoid Res ; 8(3): 445-463, 2023 06.

Article em En | MEDLINE | ID: mdl-36745405

Assuntos

Canabinoides; Infecções por HIV; Soropositividade para HIV; HIV-1; Humanos; Endocanabinoides/metabolismo; HIV-1/metabolismo; Doenças Neuroinflamatórias; Receptores de Canabinoides/metabolismo; Transtornos Neurocognitivos/tratamento farmacológico; Infecções por HIV/tratamento farmacológico

Palavras-chave

2-arachidonoylglycerol; HIV-associated neurocognitive disorders; N-arachidonylethanolamine; cannabinoid receptors; endocannabinoid system

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Canabinoides / Infecções por HIV / HIV-1 / Soropositividade para HIV Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google